Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Blood (2022) 140 (24): 2584–2593.

https://doi.org/10.1182/blood.2022016945

Published: 2022

Journal Articles

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry

Blood (2021) 138 (Supplement 1): 92.

https://doi.org/10.1182/blood-2021-150721

Published: 2021

Journal Articles

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry

Blood (2021) 138 (Supplement 1): 885.

https://doi.org/10.1182/blood-2021-150994

Published: 2021

Journal Articles

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Blood (2021) 138 (Supplement 1): 743.

https://doi.org/10.1182/blood-2021-148626

Published: 2021

Journal Articles

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Blood (2018) 132 (Supplement 1): 1629.

https://doi.org/10.1182/blood-2018-99-118578

Published: 2018

Journal Articles

Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network

Blood (2016) 128 (22): 784.

https://doi.org/10.1182/blood.V128.22.784.784

Published: 2016

Journal Articles

Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs

Daniel Olive, MD, PhD, Suong Khieu LE, PhD, marie-Laure Thibult, Francoise gondois-Rey, Samuel Granjeaud, PhD, Thierry Fest, Azzaoui Imene, Reda Bouabdallah, MD, Florence Broussais, Luc Xerri, Dominique Leroux, Christophe Caux, Christine Caux

Blood (2015) 126 (23): 5018.

https://doi.org/10.1182/blood.V126.23.5018.5018

Published: 2015

Journal Articles

A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Non-Leukemic Hematologic Malignancies

Catherine Thieblemont, MD PhD, Anastasios Stathis, MD, Giorgio Inghirami, MD, Lionel Karlin, Franck Morschhauser, MD PhD, Mary Gleeson, FRCPath, Florence Broussais, MD, Sandy Amorim, MD, Gilles Salles, MDPhD, Thierry Facon, MD, David Cunningham, FMedSci, Norbert Vey, MD PhD, Fabrice Bourdel, MSc, Patrice Herait, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 4417.

https://doi.org/10.1182/blood.V124.21.4417.4417

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma

Sylvain Garciaz, MD, Diane Coso, MD, Florence Broussais, MD, Jean-Marc Schiano, MD, Boris Calmels, PharmD, PhD, Colombe Saillard, MD, Lauris Boudin, MD, Sophie Amrane, Didier Blaise, MDPhD, Reda Bouabdallah, MD

Blood (2014) 124 (21): 2515.

https://doi.org/10.1182/blood.V124.21.2515.2515

Published: 2014

Journal Articles

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Julien Lazarovici, MD, Pauline Brice, MD, Lucie Obéric, MD, Isabelle Gaillard, MD, Mathilde Hunault-Berger, MD PhD, Florence Broussais, MD, Serge Bologna, MD, Emmanuel Gyan, MD PhD, Catherine Sebban, MD, Mohamed Touati, MD, Richard Delarue, MD, Frédérique Orsini-Piocelle, MD, Aspasia Stamatoullas, MD, Peggy Dartigues, MD, Marc PE André, MD, Olivier Casasnovas, MD, Nicolas Mounier, MD PhD, Christophe Fermé, MD

Blood (2014) 124 (21): 3054.

https://doi.org/10.1182/blood.V124.21.3054.3054

Published: 2014

Journal Articles

Impact of Partial Response Versus Complete Response before RIC/RTC Allogeneic Stem Cell Transplantation on Survival in a Cohort of 115 Chemosensitive Advanced NHL

Sylvain Garciaz, MD, Anne Wanquet, MD, Luca Castagna, MD, Roberto Crocchiolo, MD, Sabine Fürst, MD, Samia Harbi, MD, Christian Chabannon, MD PhD, Florence Broussais, MD, Diane Coso, MD, Reda Bouabdallah, MD, Didier Blaise, MD

Blood (2014) 124 (21): 1246.

https://doi.org/10.1182/blood.V124.21.1246.1246

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Daniel Olive, MD, PhD, Kieu Suong Le, Mikael Roussel, MD PhD, Florence Broussais, MD, Imane Azzaoui, PhD, Delphine Rossille, Reda Bouabdallah, MD, Thierry Fest, MD PhD, Luc Xerri, Thierry Lamy, MD PhD, Céline Pangault, PharmD, PhD

Blood (2014) 124 (21): 1665.

https://doi.org/10.1182/blood.V124.21.1665.1665

Published: 2014

Journal Articles

CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8 fc ) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin’S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern

Suong Le Thi, M.D., Florence Broussais, Reda Bouabdallah, MD, Françoise gondois-Rey, Luc Xerri, MD, PhD, Daniel Olive, MD, PhD

Blood (2013) 122 (21): 4233.

https://doi.org/10.1182/blood.V122.21.4233.4233

Published: 2013

Journal Articles

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Adrien Trebouet, Tony Marchand, Richard Lemal, Emmanuel Gyan, MD, PhD, Florence Broussais, MD, Yann Guillermin, MD, Hélène Monjanel, Gilles Salles, MD, Steven Le Gouill, Stephanie Boulanger, Sandra Leguyader, Albert Collignon, Delphine Rossille, PhD, Catherine Thieblemont, MD, PhD, Thierry Lamy, MD, PhD, Roch Houot, MD, PhD

Blood (2012) 120 (21): 1582.

https://doi.org/10.1182/blood.V120.21.1582.1582

Published: 2012

Journal Articles

Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Vadim Ivanov, MD, PhD, Diane Coso, MD, Thérèse Aurran, MD, Jean Marc Schiano, MD, Anne-Marie Stoppa, MD, Jerome Rey, MD, Florence Broussais, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2012) 120 (21): 3695.

https://doi.org/10.1182/blood.V120.21.3695.3695

Published: 2012

Journal Articles

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

Roberto Crocchiolo, MD PhD, Sabine Fuerst, MD, Jean El-Cheikh, MD PhD, Angela Granata, Claire Oudin, Geoffroy Venton, Norbert Vey, Reda Bouabdallah, MD, Anne Marie Stoppa, Florence Broussais, MD, Aude Charbonnier, MD, PhD, Claude Lemarie, Diane Coso, MD, Thomas Prebet, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3029.

https://doi.org/10.1182/blood.V120.21.3029.3029

Published: 2012

Journal Articles

A Restrospective Review of Peripheral T-Cell Lymphoma in a Single Institution Between 2000 and 2010

Florence Broussais, MD, Diane Coso, MD, Vadim Ivanov, MD, PhD, Thérèse Aurran, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 1623.

https://doi.org/10.1182/blood.V118.21.1623.1623

Published: 2011

Journal Articles

Diffuse Large B-Cell Lymphoma in the Elderly: Outcome of Patients From a Single Center

Jean-Marc Schiano de Colella, MD, Diane Coso, MD, Benjamin Esterni, Ph.D., Anne-Marie Stoppa, Vadim Ivanov, MD, PhD, Thérèse Aurran, MD, Florence Broussais, MD, Jerome Rey, MD, Frederique Rousseau, MD, Maud Cecile, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 2693.

https://doi.org/10.1182/blood.V118.21.2693.2693

Published: 2011

Journal Articles

Potential Synergic Effect of Lenalidomide-Rituximab Combination: Durable Complete Remissions in Refractory Diffuse Large B Cell Lymphoma

Vadim Ivanov, MD, PhD, Diane Coso, MD, Therese Aurran-Schleinitz, MD, Jean-Marc Schiano de Colella, MD, Anne-Marie Stoppa, MD, Jerome Rey, MD, Florence Broussais, MD, Didier Blaise, MD, Reda Bouabdallah, MD

Blood (2011) 118 (21): 4989.

https://doi.org/10.1182/blood.V118.21.4989.4989

Published: 2011

Journal Articles

Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.

Richard Delarue, MD, Corinne Haioun, MD, Florence Broussais-Guillaumot, MD, David Sibon, MD, Marion Fournier, Nicolas Mounier, MD, Tony Petrella, MD, Serge Bologna, MD, Christophe Fruchart, MD, Christophe Ferme, MD, Christian Recher, MD, PhD, Stephanie Picard, Herve Tilly, MD, Andre Bosly, MD, PhD

Blood (2009) 114 (22): 1701.

https://doi.org/10.1182/blood.V114.22.1701.1701

Published: 2009

NARROW

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network

Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs

A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Non-Leukemic Hematologic Malignancies

Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Impact of Partial Response Versus Complete Response before RIC/RTC Allogeneic Stem Cell Transplantation on Survival in a Cohort of 115 Chemosensitive Advanced NHL

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8 fc ) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin’S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

A Restrospective Review of Peripheral T-Cell Lymphoma in a Single Institution Between 2000 and 2010

Diffuse Large B-Cell Lymphoma in the Elderly: Outcome of Patients From a Single Center

Potential Synergic Effect of Lenalidomide-Rituximab Combination: Durable Complete Remissions in Refractory Diffuse Large B Cell Lymphoma

Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only